These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 9398274)
1. A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus. Ghosh JK; Ovadia M; Shai Y Biochemistry; 1997 Dec; 36(49):15451-62. PubMed ID: 9398274 [TBL] [Abstract][Full Text] [Related]
2. Membrane-induced step in the activation of Sendai virus fusion protein. Ben-Efraim I; Kliger Y; Hermesh C; Shai Y J Mol Biol; 1999 Jan; 285(2):609-25. PubMed ID: 9878433 [TBL] [Abstract][Full Text] [Related]
3. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion. Ghosh JK; Shai Y J Mol Biol; 1999 Sep; 292(3):531-46. PubMed ID: 10497019 [TBL] [Abstract][Full Text] [Related]
4. Structure-function study of a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion. Ghosh JK; Peisajovich SG; Ovadia M; Shai Y J Biol Chem; 1998 Oct; 273(42):27182-90. PubMed ID: 9765238 [TBL] [Abstract][Full Text] [Related]
5. Sendai virus internal fusion peptide: structural and functional characterization and a plausible mode of viral entry inhibition. Ghosh JK; Peisajovich SG; Shai Y Biochemistry; 2000 Sep; 39(38):11581-92. PubMed ID: 10995225 [TBL] [Abstract][Full Text] [Related]
6. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes. Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286 [TBL] [Abstract][Full Text] [Related]
7. A peptide derived from a conserved domain of Sendai virus fusion protein inhibits virus-cell fusion. A plausible mode of action. Ghosh JK; Shai Y J Biol Chem; 1998 Mar; 273(13):7252-9. PubMed ID: 9516418 [TBL] [Abstract][Full Text] [Related]
8. Conformation and lipid binding properties of four peptides derived from the membrane-binding domain of CTP:phosphocholine cytidylyltransferase. Johnson JE; Rao NM; Hui SW; Cornell RB Biochemistry; 1998 Jun; 37(26):9509-19. PubMed ID: 9649334 [TBL] [Abstract][Full Text] [Related]
9. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Joshi SB; Dutch RE; Lamb RA Virology; 1998 Aug; 248(1):20-34. PubMed ID: 9705252 [TBL] [Abstract][Full Text] [Related]
10. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins. Lev N; Shai Y J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659 [TBL] [Abstract][Full Text] [Related]
11. Participation of two fusion peptides in measles virus-induced membrane fusion: emerging similarity with other paramyxoviruses. Samuel O; Shai Y Biochemistry; 2001 Feb; 40(5):1340-9. PubMed ID: 11170461 [TBL] [Abstract][Full Text] [Related]
12. A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers. Kliger Y; Shai Y Biochemistry; 1997 Apr; 36(17):5157-69. PubMed ID: 9136877 [TBL] [Abstract][Full Text] [Related]
13. The role of leucine residues in the structure and function of a leucine zipper peptide inhibitor of paramyxovirus (NDV) fusion. Young JK; Hicks RP; Wright GE; Morrison TG Virology; 1998 Mar; 243(1):21-31. PubMed ID: 9527912 [TBL] [Abstract][Full Text] [Related]
14. Fusion of Sendai virus with vesicles of oligomerizable lipids: a microcalorimetric analysis of membrane fusion. Ravoo BJ; Weringa WD; Engberts JB Cell Biol Int; 2000; 24(11):787-97. PubMed ID: 11067763 [TBL] [Abstract][Full Text] [Related]
15. Fusogenic activity of hepadnavirus peptides corresponding to sequences downstream of the putative cleavage site. Rodríguez-Crespo I; Núñez E; Yélamos B; Gómez-Gutiérrez J; Albar JP; Peterson DL; Gavilanes F Virology; 1999 Aug; 261(1):133-42. PubMed ID: 10441561 [TBL] [Abstract][Full Text] [Related]
16. Interaction of fluorescently labeled analogues of the amino-terminal fusion peptide of Sendai virus with phospholipid membranes. Rapaport D; Shai Y J Biol Chem; 1994 May; 269(21):15124-31. PubMed ID: 8195149 [TBL] [Abstract][Full Text] [Related]
17. Interaction between dengue virus fusion peptide and lipid bilayers depends on peptide clustering. Stauffer F; Melo MN; Carneiro FA; Sousa FJ; Juliano MA; Juliano L; Mohana-Borges R; Da Poian AT; Castanho MA Mol Membr Biol; 2008 Feb; 25(2):128-38. PubMed ID: 18307100 [TBL] [Abstract][Full Text] [Related]
18. Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C. West MJ; Webb HM; Sinclair AJ; Woolfson DN J Virol; 2004 Sep; 78(17):9431-45. PubMed ID: 15308737 [TBL] [Abstract][Full Text] [Related]
19. Fusion peptide-phospholipid noncovalent interactions as observed by nanoelectrospray FTICR-MS. Li Y; Heitz F; Le Grimellec C; Cole RB Anal Chem; 2005 Mar; 77(6):1556-65. PubMed ID: 15762557 [TBL] [Abstract][Full Text] [Related]
20. Amino acid substitutions in leucine zipper motif in the F-specific domain of human parainfluenza virus 3 HN protein play important roles in the protein function. Zhang W; Ren G; Wu B; Liu X; Wang G; Song Y; Xu H; Wen H; Wang Z Intervirology; 2008; 51(5):311-21. PubMed ID: 19018146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]